CRISPR Therapeutics is commercially validated with CASGEVY but remains financially unproven and operates at a loss. Click to read this CRSP stock update.
It looked like Shopify's stock was headed for a great day when it reported earnings, only for the stock to give up all its gains and then some when management started talking on the conference call.
Corporate crypto-treasury strategies are being stress-tested in major drawdowns, exposing how fragile balance sheets are. BitMine’s heavy ETH concentration has translated into a multi-billion-dollar ...
Dalton Cooper is the Managing Editor of GameRant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...
Prairie controls around 65,000 net acres in the DJ Basin. Its breakeven is in the mid-$40 oil range, and it has ten years of ...
What have you been listening to this week? Nayha reveals all. Who will knock off Asim Azhar and the Sabri Sisters', Meri Zindagi Hai Tu from the top of the chart? Or will it keep its No.1 position?
If anything, Geoff Keighley was certainly very excited for it, but many gamers have quite strong opinions on the veteran journalist and host's tastes, as immortalised by X (formerly Twitter) user ...
New Iowa legislation requires schools to report student demographic data using only male or female categories. As a result, the state's official count of nonbinary students has dropped from over 300 ...
The answer may come down to how the ratings service classifies the show in its streaming ratings. By Rick Porter Television Business Editor It’s also drawing in a large audience: According to HBO’s ...
In early February 2026, Acadia Pharmaceuticals reported that the European Medicines Agency’s Committee for Medicinal Products ...
A T cell count is a blood test that measures the number of T cells, a type of white blood cell crucial for fighting off diseases, especially viral infections. This test helps identify issues with the ...
The Trump administration has taken a big step toward curbing Medicare Advantage overpayments, proposing a rule that would stamp out one strategy insurers use to inflate their members’ sicknesses to ...